Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.
about
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-RespondersMechanisms of sickle cell alloimmunizationExtensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in AfricaHow I manage cerebral vasculopathy in children with sickle cell disease.Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.Immunoregulatory networks in sickle cell alloimmunization.Hemin controls T cell polarization in sickle cell alloimmunization.High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD AlloimmunizationEconomic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell diseaseHypertransfusion therapy in sickle cell disease in NigeriaImmunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermediaResponder individuality in red blood cell alloimmunization.Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell diseaseNext-generation sequencing is a credible strategy for blood group genotyping.The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomesDe novo generation of HSCs from somatic and pluripotent stem cell sources.Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization.The association of CD81 polymorphisms with alloimmunization in sickle cell diseaseCurrent management of sickle cell anemia.Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell diseaseAlloimmunization is associated with older age of transfused red blood cells in sickle cell diseaseRed blood cell alloimmunization in sickle cell disease: prevalence in 2010.Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients.The Lombardy Rare Donor Programme.Interventions for chronic kidney disease in people with sickle cell disease.Variants of RhD--current testing and clinical consequences.Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.Concise review: stem cell-based approaches to red blood cell production for transfusion.Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City.How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.Considerations of red blood cell molecular testing in transfusion medicine.
P2860
Q27000807-8A5A0CAE-79CB-4B8B-9F24-B684BD2C99E4Q28083189-740C8BA7-BA38-46BE-9F57-17B2E80A76ACQ28389772-C0B623E2-B519-4522-A056-D4B728FC98B6Q30945117-1F81E330-2AA1-4341-8F6F-A928062D5A3BQ33441353-94E9F55D-7A95-4C71-AEFD-2DFB90328333Q33667429-96737536-1B69-4105-96D5-A7CA400FC410Q33797355-017A8EB1-17C1-40F0-942A-7F86B298F0EEQ33863461-9F7CF7A4-30B5-4102-B068-D24EA30D4AA3Q34067039-7895418E-8811-4FE9-82F0-3EF992D69406Q34080182-1DC227F9-82B7-4ECF-8EC9-86D29A7B859EQ34459335-889B1033-E36C-480E-99B3-E130D85C123FQ34791984-6BE200CC-F269-426E-B8B7-06DF9267E511Q34792041-E4434983-45CB-496D-96C0-6990117B2990Q34792059-D0CC8023-5156-4CD7-AC45-07BD173ABB05Q34792068-C377921F-236C-43CD-BEC3-0697B959CDD9Q35049152-C8165DF8-EA7C-42B9-8B05-E42E1F47DD33Q35145919-F31E2A60-3BBF-4F98-AA3D-CBE003FC45F5Q35227620-471CA8EC-E9A7-44F4-9C51-492BDD6762D9Q35251300-9840D697-55E1-4212-9EEE-161FFBA809FDQ35533599-7B8060BC-F14F-4D79-80D4-97AC067D9040Q35541746-1F99805E-0106-4B2C-8C31-F4EBD0A444B3Q36068943-E538AE1C-51FA-4723-8715-8B9FBEFDCA35Q36187306-5817493A-186B-4851-A37A-AB85040DA44AQ36563588-8E0F86C0-13CF-43FA-9CBC-4865AA365ADAQ36779751-4C2B89BC-55BE-4BDC-9C7F-0412BB4C344EQ36907787-13C83E62-C491-44E3-B63B-372799C77FFEQ37040238-AE672DA1-DF65-4FEC-84D4-C5A9B00CBBE5Q37136211-D73E294F-629A-4152-B073-4F95E26FAF03Q37195103-6E329D35-0915-4ECE-8DFD-7D6539288911Q37254929-94EB3C25-B131-4CBC-9C67-085F71608DD6Q37394897-67D59708-8C57-4791-83B3-4FE351C96F1AQ37588941-FE67302A-9876-4FD2-AB2E-7C1A638DE412Q37602420-B4724D94-C6BD-4452-A192-0256D680BAF2Q37713880-BE0CC3BC-ED0A-4C0F-8D0B-0830B4073DC0Q38083742-6F072CA4-C8EF-4428-BAD8-020B6000E74FQ38151829-AA31F109-0993-4353-B6C4-D2A199B0BB2EQ38173213-CCE94F12-5CCF-452D-8397-538B1268285DQ38396697-21F0DDF1-9341-420A-AE79-FEC8290F0EE2Q38476241-155D404B-5F1A-49B1-9094-18C7793CAD65Q38586467-FFFA64B2-D2C4-4525-B2D9-8E8EBAD5D58D
P2860
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Red blood cell alloimmunizatio ...... s, and transfusion management.
@ast
Red blood cell alloimmunizatio ...... s, and transfusion management.
@en
type
label
Red blood cell alloimmunizatio ...... s, and transfusion management.
@ast
Red blood cell alloimmunizatio ...... s, and transfusion management.
@en
prefLabel
Red blood cell alloimmunizatio ...... s, and transfusion management.
@ast
Red blood cell alloimmunizatio ...... s, and transfusion management.
@en
P2093
P2860
P1433
P1476
Red blood cell alloimmunizatio ...... s, and transfusion management.
@en
P2093
France Noizat-Pirenne
Karina Yazdanbakhsh
Russell E Ware
P2860
P304
P356
10.1182/BLOOD-2011-11-327361
P407
P577
2012-05-04T00:00:00Z